| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d5fe74855697fef20a2e98a9b005db19 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07J75-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-14 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07J1-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07J41-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-62
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07J75-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-568
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-567
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/B01D9-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-36 |
| filingDate |
2003-04-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b3cea943e7de512fb3ddf2f5126aff39
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8a6205d9a97dfa1d0069d15995264084
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_86df651295843a8ed73655b14f322ebc
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_30970cee11b9ac7e0e195d1de19ddcd6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_080309b3bde60f0a263096d7ee633da9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3fef18ec2a906a2d52125570e5465a33 |
| publicationDate |
2003-11-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-03090721-A2 |
| titleOfInvention |
Method for producing crystals from active ingredients in medicaments, and the use thereof in pharmaceutical formulations |
| abstract |
The invention relates to a method for producing crystallines from active ingredients in medicaments, the average particle size thereof lying within a given range and the maximum particle size thereof not exceeding a given value. During crystallisation, an oversaturated solution is subjected to wet milling by means of a wet milling device; as a result, a primary grain suspension is obtained. The invention also relates to crystals obtained according to said method and pharmaceutical formulations containing said crystals. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9745250-B2 |
| priorityDate |
2002-04-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |